Tag: Radiopharmaceuticals

Isotopia and Bar-Ilan University intend to develop a new radioactive marker

radiopharmaceutical
The Israeli Isotopia Company, in collaboration with Prof. Rachela Popovtzer of Bar-Ilan University's Faculty of Engineering, is conducting a joint study to develop a radioactive marker for the detection of cancer.

IRM plans to launch manufacturing of its first radiopharmaceuticals in 2019

irm
A Nuclear Medicine Center may be soon established in the Ural region as a result of efforts by the specialists of the Institute of Reactor Materials (an enterprise of Scientific Division of Rosatom State Corporation).

Endocyte and ITM signed a long-term global supply agreement

radiopharmaceuticals
Endocyte and ITM Isotopen Technologien München AG (ITM) announced that ITM´s subsidiary and Endocyte have signed a long-term global supply agreement for the highly purified, no-carrier-added Lutetium-177 (177Lu) EndolucinBeta.

New cyclotron in St. Petersburg will help to develop a novel biomarker

radiopharmaceutical drug
Russia’s first new generation cyclotron (accelerator of particles) intended for manufacturing pharmaceuticals for cancer diagnosis was installed at Dr. Berezin Medical Institute (MIBS) in St. Petersburg.

Telix Pharmaceutical sets up research partnership with INSERM and ARRONAX

radiopharmaceuticals
Telix Pharmaceuticals announced a research partnership with the French National Institute of Health and Medical Research and the “Accelerator for Research in Radiochemistry and Oncology at Nantes Atlantic”.

Actinium Pharmaceuticals and Astellas will collaborate on a radiopharmaceutical

radiopharmaceuticals
Actinium Pharmaceuticals entered into a research and option agreement with Astellas Pharma to develop Actinium-225 Radio-Conjugates (ARCs) using its Actinium Warhead Enabling (AWE) Platform Technology.

Kaluga is expected to complete its program for radiopharmaceuticals in two years

radiopharmaceutical drug
Kaluga pharmaceutical cluster recently increased the number of locally manufactured drugs from 65 to 154. The Governor expects that the region needs 2 years to complete its import substitution program for radiopharmaceuticals.

National PET-Technology network covers nine Russian regions

PET-Technology
PET-Technology, the national network of nuclear medicine centers established with the RUSNANO support, opened its 10th center in Samara. The investments in Samara center amounted to more than 410 million rubles.

UrFU researchers will create methods for targeted delivery of cancer drugs

bazhukov
The scientists at the Cyclotron Center for Nuclear Medicine of the Ural Federal University will design new methods for targeted delivery of drugs to the malignant tumor location

Russian scientists receive award for unique R&D in the area of oncology

pharma
The award of the Government of the Russian Federation was given for the development, manufacturing and implementation of Russian radioactive sources for contact radiation therapy

Telix Pharmaceuticals will transfer its technology to Japan

radiology
Telix Pharmaceuticals, a biopharmaceutical company focused on the development of targeted radiopharmaceuticals or “molecularly-targeted radiation”, announced the establishment Telix Pharmaceuticals Japan

USU will develop technology for manufacturing radiopharmaceuticals

radiopharmaceutical drug
A center for personalized nuclear medicine was opened on the basis of the Ulyanovsk State University. The new center will ensure the development of technology for manufacturing the radiopharmaceuticals.

Novartis plans to buy French radiopharmaceutical company

radiopharmaceutical
Global healthcare company Novartis has announced plans to acquire Advanced Accelerator Applications, a radiopharmaceutical firm established by physicist Stefano Buono in 2002

Norgine launches a new radiopharmaceutical in Finland and Sweden

radiopharmaceuticals
Norgine B.V. today announced the launch of LYMPHOSEEK® (Tc 99m tilmanocept) in Finland and Sweden

Tomsk researchers develop a radiopharmaceutical based on gamma aluminum oxide

research
The scientists at the Cancer Research Institute are developing a drug for diagnosis of cancer metastases in sentinel lymph nodes

Radiopharmaceutical developed in Tomsk may compete with PET

radiopharmaceuticals
The scientists from the Cancer Research Institute are testing a radiopharmaceutical based on technetium labeled glucose